GATA-binding protein 3 (GATA3), secreted primarily by TAMs in high-grade serous ovarian cancer, promotes tumor progression, angiogenesis, and chemotherapy resistance. This evidence concerns the gene GATA3 and ovarian serous adenocarcinoma.